Dietitians who see clients with pre-diabetes (who are at an increased risk of developing Type 2 diabetes) can learn more about how Barliv™ barley betafiber can help address this issue at a poster session on Monday, Sept. 26, during the American Dietetic Association’s 2011 Food & Nutrition Conference & Expo in San Diego, Calif. The latest research on Barliv™ barley betafiber, titled Dietetics Practice: Maintaining Weight in a Clinical Trial Testing a Nutritive Beverage in Subjects at High Risk for Type 2 Diabetes, will be presented and focuses on the dietary research within the trial. The full peer-reviewed paper was recently published in Nutrition and Metabolism.
The 12-week randomized, placebo controlled, double blind, clinical-glucan (Barliv™ barley betafiber)btrial assessed the impact of barley on glucose levels and insulin sensitivity. Because weight changes can impact both of these variables, the researchers took steps to ensure that the 50 healthy participants—each at risk for type 2 diabetes mellitus—kept their weight constant during the trial period. Participants consumed three low-dose (three grams Barliv™ barley betafiber/day) or high-dose (six grams Barliv™ barley betafiber/day) 11-ounce test beverages each day with their meals. The findings suggest that six grams/day of Barliv™ barley betafiber over 12 weeks can improve insulin sensitivity among generally healthy people with pre-diabetes, who have no prior diagnosis of diabetes mellitus.
“Type 2 diabetes is a major national health concern which makes us enthusiastic about these findings,” said Lore Kolberg, associate director, Cargill Regulatory and Scientific Affairs. “Prior studies suggest that soluble fibers have a positive effect on glucose homeostasis. This most recent research further supports the benefit of such ingredients as Barliv™ barley betafiber for individuals with pre-diabetes who are trying to maintain healthy glucose and insulin levels.”
Developed by Cargill, Barliv™ barley betafiber is a natural soluble fiber made from barley and backed by a U.S. Food & Drug Administration( FDA) health claim* for its cholesterol-lowering benefits. Research has concluded that Barliv™ barley betafiber significantly reduces LDL cholesterol and total cholesterol levels without adversely affecting HDL cholesterol.
Barliv™ barley betafiber is currently available in a variety of beverages, snacks and cereals in Europe. Look for U.S. product launches in the near future. For additional information, visit www.barliv.com.
*FDA Authorized Health Claim: Diets low in saturated fat and cholesterol that include 3 grams per day of beta-glucan soluble fiber from barley betafiber may reduce the risk of heart disease.
Cargill is an international producer and marketer of food, agricultural, financial and industrial products and services. Founded in 1865, the privately held company employs 130,000 people in 63 countries. Cargill helps customers succeed through collaboration and innovation, and is committed to applying its global knowledge and experience to help meet economic, environmental and social challenges wherever it does business. For more information, visit www.cargill.com.